Snapshot from Apr 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Oncoinvent
Entity

Oncoinvent

Tracked across 1 events · 7 articles · First seen Feb 26, 2026 · Last active Feb 26, 2026

Sentiment
50
Attention
2
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 50
Business
Oncoinvent Announces Positive 2H 2025 Results
Oncoinvent announced positive second half 2025 results, including advancements in its Radspherin clinical programs for ovarian and colorectal cancer. The company also completed a merger with BerGenBio, uplisted to the Oslo Stock Exchange, and raised NOK 130 million in equity, strengthening its financial position.
Feb 26, 2026 · 7 articles
Relationships (2)
Øystein Soug CEO ↔ Oncoinvent Øystein Soug is the Chief Executive Officer of Oncoinvent.
Ramzi Amri CFO ↔ Oncoinvent Ramzi Amri was appointed as the Chief Financial Officer of Oncoinvent.
NEWSDESK
Track Oncoinvent live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.